Plain-English translation of NCT05835622 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research is testing a wearable robotic device called Keeogo that helps people with multiple sclerosis walk more safely and easily. You would use the device at home for several weeks while researchers measure how it affects your daily life, mobility, and confidence. The study compares periods when you use the device with periods when you follow regular exercise advice, to see which approach helps you most.
Many people with multiple sclerosis struggle with walking and need assistive devices, but there are limited options to improve their mobility and independence. This trial explores whether a wearable robotic exoskeleton can help restore walking ability and improve overall quality of life for people living with this challenge.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to one of two groups that receive the device at different times. First, you would attend 5 days of training to learn how to use Keeogo safely and comfortably. Then you would take the device home for 7 weeks and use it as much as possible during your daily activities indoors and outdoors. You would also have an 8-week comparison period where you follow standard physical activity recommendations at home. The study includes an 8-week break between phases and ends with 3 months of follow-up to see how you're doing.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France